Pomegra
Rocket Lab (RKLB) posted record Q3 2026 revenue of $268M, up 73%, and a $3.57B backlog, but a wider-than-expected loss sent shares lower in after-hours trading.
- Q3 revenue reached $267.8M, up 73% year over year, against consensus of about $257M.
- Backlog rose 52% sequentially to $3.57B, including more than $515M in new Neutron contracts.
- Shares fell roughly 4% after hours on a $0.12 per-share loss versus a $0.07 consensus loss.
Lead
Rocket Lab reported third-quarter 2026 results after the close on Monday, November 9. Record revenue of $267.8M was up 73% from a year earlier, $34M above the second quarter and ahead of both the company's $250M-$265M guidance range and consensus of about $257M. The report followed a gain of roughly 28% in the stock over the prior two sessions, which had lifted expectations for the quarter. Shares slipped about 4% in extended trading as the loss widened.What Did Rocket Lab Report for Q3 2026?
Rocket Lab reported its sixth consecutive record revenue quarter, with $197.5M from products and $70.3M from services. GAAP gross margin was 33.6% and non-GAAP gross margin was 38.4%.
The GAAP net loss widened to $79.7M from $18.3M in the year-earlier quarter. The adjusted loss was $0.12 per share, against a consensus loss of $0.07. Adjusted EBITDA was a loss of about $18.0M. Operating cash flow was positive at $7.2M, a milestone for a company still investing heavily in its next-generation rocket.
Total backlog reached about $3.57B, up roughly $1.2B, or 52%, from the end of the second quarter. About $1B of new launch contracts were signed across Electron, HASTE and Neutron. That took the launch backlog to a record 117 missions.
Why Did Rocket Lab Shares Fall Despite the Beat?
Shares fell because the earnings miss and the rising cost of development outweighed the revenue beat. The stock had entered the report on a sharp advance as space-sector names rebounded from the previous week's selloff, which left little room for a profitability shortfall. The $0.05 per-share gap against consensus, together with a GAAP loss more than four times larger than a year earlier, drew the immediate selling.
The decline was modest next to the preceding run. Fourth-quarter guidance also came in above expectations, which limited the damage in extended trading.
What Does the Neutron Backlog Mean for Growth?
The Neutron backlog gives Rocket Lab a funded demand base for a vehicle that has not yet flown. The company signed more than $515M of Neutron launch contracts from constellation operators during the quarter, lifting the manifest to 16 missions ahead of the debut. The base price for several of these missions rose to $70M from $55M as industry launch capacity tightens.
Neutron's first launch is targeted for no earlier than 2027. Until then, the medium-lift program remains a source of spending rather than revenue. That timing is the main reason investors weigh near-term losses against the contracted pipeline. Higher pricing suggests customers are willing to pay for access to reusable medium-lift capacity, a segment where supply is limited.
Strategic Context
Rocket Lab is positioning itself as a vertically integrated space company rather than only a small-launch provider. Twelve Rocket Lab-built spacecraft are now launched and operating, and more than 55 are in development across its production facilities. Spacecraft manufacturing, components and launch services increasingly feed one another. The satellite work supplies steady revenue while Electron cadence builds a track record that supports Neutron sales.
Government-linked work, including HASTE hypersonic test flights, adds a defense revenue stream that is less exposed to commercial constellation funding cycles. The mix lifts the backlog and gives management more visibility than a launch-only model would.
What Comes Next for Rocket Lab's Margins and Guidance?
Rocket Lab guided fourth-quarter revenue to $270M-$290M, above the consensus of about $265.5M. The midpoint implies sequential growth of roughly 4.5%. GAAP gross margin is guided to 34%-36% and non-GAAP gross margin to 39%-41%, which would be an expansion from the 38.4% reported in the third quarter.
Margin direction will matter as much as the revenue line. The next tests are how quickly Neutron development spending peaks, how much of the new backlog converts to revenue in 2027, and whether the positive operating cash flow can be sustained as spending rises.
Outlook
Rocket Lab ended the quarter with record revenue, a backlog of about $3.57B and guidance above consensus. The stock's reaction reflected a sharp pre-earnings run and a larger loss, not a deterioration in demand. Neutron's 2027 debut window, Q4 margin delivery and cash generation will shape how the market values the backlog in coming quarters.
